Molecular mechanisms of immune-mediated lysis of murine renal cancer: Differential contributions of perforin-dependent versus fas-mediated pathways in lysis by NK and T cells

Journal of Immunology

Volumn 161, Issue 8, 1998, Pages 3957-3965

  Sayers, Thomas J ^a   Brooks, Alan D ^a   Lee, Jong Keuk ^b   Fenton, Robert G ^b   Komschlies, Kristin L ^a   Wigginton, Jon M ^c   Winkler Pickett, Robin ^b   Wiltrout, Robert H ^b  

^a SAIC FREDERICK INC   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

^c NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FAS LIGAND; GAMMA INTERFERON; PERFORIN; STAUROSPORINE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CANCER IMMUNOLOGY; CANCER IMMUNOTHERAPY; CELL MEDIATED CYTOTOXICITY; CONTROLLED STUDY; CYTOLYSIS; CYTOTOXICITY; KIDNEY CANCER; MOUSE; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE;

ANIMALS; ANTIGENS, CD95; CELL DEATH; CYTOTOXICITY, IMMUNOLOGIC; KIDNEY NEOPLASMS; KILLER CELLS, NATURAL; MEMBRANE GLYCOPROTEINS; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; NEOPLASMS, EXPERIMENTAL; PORE FORMING CYTOTOXIC PROTEINS; SIGNAL TRANSDUCTION; T-LYMPHOCYTES;

EID: 0032532283     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (71)

1. Wiltrout, R. H., M. R. Boyd, T. C. Back, R. R. Salup, J. A. Arthur, and R. L. Hornung. 1988. Flavone-8-acetic acid augments systemic natural killer cell activity and synergizes with IL-2 for the treatment of murine renal cancer. J. Immunol. 140:3261.
2. Hornung, R. L., T. C. Back, D. S. Zaharko, W. J. Urba, D. L. Longo, and R. H. Wiltrout. 1988. Augmentation of natural killer cell activity, induction of IFN, and development of tumor immunity during the successful treatment of established murine renal cancer using flavone acetic acid and IL-2. J. Immunol. 141:3671.
3. Wigginton, J. W., K. L. Komschlies, T. C. Back, J. L. Franco, M. J. Brunda, and R. H. Wiltrout. 1996. Administration of interleukin 12 with pulse interleukin 2 and the rapid and complete eradication of murine renal cancer. J. Natl. Cancer Inst. 88:38.
4. Asano, T., A. Khanna, M. Lagman, B. Li, and M. Suthanthiran. 1997. Immunostimulatory therapy with anti-CD3 monoclonal antibodies and recombinant interleukin-2: heightened in vivo expression of mRNA encoding cytotoxic attack molecules and immunoregulatory cytokines and regression of murine renal cancer. J. Urol. 157:2396.
5. Sayers, T. J., T. A. Wiltrout, K. McCormick, C. Husted, and R. H. Wiltrout. 1990. Antitumor effects of α-interferon and γ-interferon on a murine renal cancer (Renca) in vitro and in vivo. Cancer Res. 50:5414.
6. Wiltrout, R. H. 1991. The immunotherapy of murine renal cancer. Prog. Neuroendocrinimmunol. 4:154.
7. Kägi, D., B. Ledermann, K. Burki, P. Seiler, B. Odermatt, K. J. Olsen, E. R. Podack, R. M. Zinkernagel, and H. Hengartner. 1994. Cytotoxicity mediated by T cells and natural killer cells is greatly impaired in perforin-deficient mice. Nature 369:31.
8. Podack, E. R. 1995. Execution and suicide: cytotoxic lymphocytes enforce draconian laws through separate molecular pathways. Curr. Opin. Immunol. 7:11.
9. Liu, C., C. M. Walsh, and J. D-E. Young. 1995. Perforin: structure and function. Immunol. Today 16:194.
10. Nagata, S., and P. Golstein. 1995. The Fas death factor. Science 267:1449.
11. Berke, G. 1997. The Fas-based mechanism of lymphocytotoxicity. Hum. Immunol. 54:1.
12. Henkart, P. A. 1994. Lymphocyte-mediated cytotoxicity: two pathways and multiple effector molecules. Immunity 1:343.
13. Grell, M., P. H. Krammer, and P. Scheurich. 1994. Segregation of APO-1/Fas antigen- and tumor necrosis factor receptor-mediated apoptosis. Eur. J. Immunol. 24:2563.
14. Wong, G. H. W., and D. V. Goeddel. 1994. Fas antigen and p55 TNF receptor signal apoptosis through distinct pathways. J. Immunol. 152:1751.
15. Watanabe-Fukunga, R., C. I. Brannan, N. G. Copeland, N. A. Jenkins, and S. Nagata. 1992. Lymphoproliferative disorder in mice explained by defects in Fas antigen that mediates apoptosis. Nature 356:314.
16. Takahashi, T., M. Tanaka, C. I. Brannan, N. A. Jenkins, N. G. Copeland, T. Suda, and S. Nagata. 1994. Generalized lymphoproliferative disease in mice, caused by a point mutation in the Fas ligand. Cell 76:969.
17. Kägi, D., P. Seiler, J. Pavlovic, B. Ledermann, K. Bürkí, R. M. Zinkernagel, and H. Hengartner. 1995. The roles of perforin- and Fas-dependent cytotoxicity in protection against cytopathic and noncytopathic viruses. Eur. J. Immunol. 25:3256.
18. + T cells clear influenza virus by perforin or Fas-dependent processes. J. Immunol. 159:5197.
19. Trauth, B. C., C. Klas, A. M. J. Peters, S. Matzuku, P. Möller, W. Falk, K. Debatin, and P. H. Krammer. 1989. Monoclonal antibody-mediated tumor regression by induction of apoptosis. Science 245:301.
20. Weller, M., K. Frei, P. Groscurth, P. H. Krammer, Y. Yonekawa, and A. Fontana. 1994. Anti-Fas/APO-1 antibody-mediated apoptosis of cultured human glioma cells: induction and modulation of sensitivity by cytokines. J. Clin. Invest. 94:954.
21. Nonomura, N., T. Miki, M. Yokoyama, T. Imazu, T. Takada, S. Takeuchi, N. Kanno, K. Nishimura, Y. Kojima, and A. Okuyama. 1996. Fas/APO-1-mediated apoptosis in human renal cell carcinoma. Biochem. Biophys. Res. Commun. 229:945.
22. Keane, M. M., S. A. Ettenberg, G. A. Lowery, E. K. Russell, and S. Lipkowicz. 1996. Fas expression and function in normal and malignant breast cell lines. Cancer Res. 56:4791.
23. Owen-Schaub, L. B., R. Radinsky, E. Kruzel, K. Berry, and S. Yonehara. 1994. Anti-Fas on nonhematopoetic tumors: levels of Fas/APO-1 and bcl-2 are not predictive of biological responsiveness. Cancer Res. 54:1580.
24. van den Broek, M. F., D. Kägi, F. Ossendorp, R. Toes, S. Vamvakas, W. K. Lutz, C. J. M. Melief, R. M. Zinkernagel, and H. Hengartner. 1996. Decreased tumor surveillance in perforin-deficient mice. J. Exp. Med. 184:1781.
25. Smyth, M. J., M. H. Kershaw, and J. A. Trapani. 1997. Xenospecific cytotoxic T lymphocytes: potent lysis in vitro and in vivo. Transplantation 63:1171.
26. Smyth, M. J., V. R. Sutton, M. H. Kershaw, and J. A. Trapani. 1996. Xenospecific cytotoxic T lymphocytes use the perforin- and Fas-mediated lytic pathways. Transplantation 62:1529.
27. Zornig, M., A. Grzeschiczek, M.-B. Kawalski, K.-U. Hartmann, and T. Moroy. 1995. Loss of Fas/Apo-1 receptor accelerates lymphomagenesis in Eu L-MYC transgenic mice but not in animals infected with MoMuLV. Oncogene 10:2397.
28. 111indium-oxine. J. Immunol. Methods 43:319.
29. Zheng, L., G. Fisher, R. E. Miller, J. Pershon, D. H. Lynch, and M. J. Lenardo. 1995. Induction of apoptosis in mature T cells by tumor necrosis factor. Nature 377:348.
30. Hornung, F., L. Zheng, and M. J. Lenardo. 1997. Maintenance of clonotype specificity in CD95/Apo-1/Fas-mediated apoptosis of mature T lymphocytes. J. Immunol. 159:3816.
31. Vignaux, F., E. Vivier, B. Malissen, V. Depaetere, S. Nagata, and P. Golstein. 1995. TCR/CD3 coupling to Fas-based cytotoxicity. J. Exp. Med. 181:781.
32. Ju, S., D. J. Panka, H. Cui, R. Ettinger, M. El-Khatib, D. H. Sherr, B. Z. Stanger, and A. Marshak-Rothstein. 1995. Fas(CD95)/FasL interactions required for programmed cell death after T cell activation. Nature 373:444.
33. Kayagaki, N., N. Yamaguchi, F. Nagao, S. Matsuo, H. Maeda, K. Okumura, and H. Yagita. 1997. Polymorphism of murine Fas ligand that affects biological activity. Proc. Natl. Acad. Sci. USA 94:3914.
34. Raff, M. C. 1992. Social controls on cell survival and cell death. Nature 356:397.
35. Thompson, C. B. 1995. Apoptosis in the pathogenesis and treatment of disease. Science 267:1456.
36. Watanabe-Fukunaga, R., C. I. Brannan, N. Itoh, S. Yonehara, N. G. Copeland, N. A. Jenkins, and S. Nagata. 1992. The cDNA stucture, expression, and chromosome assignment of the mouse Fas antigen. J. Immunol. 148:1274.
37. Bellgrau, D., D. Gold, H. Selawry, J. Moore, A. Franzusoff, and R. C. Duke. 1995. A role for CD95 ligand in preventing graft rejection. Nature 377:630.
38. Griffith, T. S., T. Brunner, S. M. Fletcher, D. R. Green, and T. A. Ferguson. 1995. Fas ligand-induced apoptosis as a mechanism of immune privilege. Science 270:1189.
39. Nagata, S. 1997. Apoptosis by death factor. Cell 88:355.
40. Sabelko, K. A., K. A. Kelly, M. H. Cross, and J. H. Russell. 1997. Fas and Fas ligand enhance the pathogenesis of experimental allergic encephalomyelitis, but are not essential for immune privilege in the central nervous system. J. Immunol. 159:3096.
41. Waldner, H., R. A. Sobel, E. Howard, and V. K. Kuchroo. 1997. Fas- and FasL-deficient mice are resistant to induction of autoimmune encephalomyelitis. J. Immunol. 159:3100.
42. Bobé, P., D. Bonardelle, M. Reynès, F. Godeau, J. Mahiou, V. Joulin, and N. Kiger. 1997. Fas-mediated liver damage in MRL hematopoetic chimeras undergoing lpr-mediated graft-versus-host disease. J. Immunol. 159:4197.
43. Smyth, M. J. 1997. Fas ligand-mediated bystander lysis of syngeneic cells in response to an allogeneic stimulus. J. Immunol. 158:5765.
44. Ando, K., K. Hiroishi, T. Kanedo, T. Moriyama, Y. Muto, N. Kayagaki, H. Yagita, K. Okumura, and M. Imawari. 1997. Perforin, Fas/Fas ligand, and TNF-α pathways as specific and bystander killing mechanisms of hepatitis C virus-specific human CTL. J. Immunol. 158:5283.
45. Fellenberg, J., H. Mau, C. Scheuerflug, V. Ewerbeck, and K. Debatin. 1997. Modulation of resistance to anti-APO-1-induced apoptosis in osteosarcoma cells by cytokines. Int. J. Cancer 72:536.
46. Peska, S. 1997. The interferon receptors. Semin. Oncol. 24:S9-18.
47. Vandenabeele, P., W. Declercq, R. Beyaert, and W. Fiers. 1997. Two tumor necrosis factor receptors: structure and function. Trends Cell Biol. 5:392.
48. Chinnaiyan, A. M., K. O'Rourke, M. Tewari, and V. M. Dixit. 1995. FADD, a novel death domain-containing protein, interacts with the death domain of Fas and initiates apoptosis. Cell 81:505.
49. Boldin, M. P., E. E. Varfolomeev, Z. Pancer, I. L. Mett, J. H. Chamonis, and D. Wallach. 1995. A novel protein that interacts with the death domain of Fas/APO1 contains a sequence motif related to the death domain. J. Biol. Chem. 270:7795.
50. Boldin, M. P., T. M. Goncharov, Y. V. Goltsev, and D. Wallach. 1996. Involvement of MACH, a novel MORT/FADD-interacting protease. in Fas/APO-1- and TNF receptor-induced cell death. Cell 85:803.
51. Muzio, M., A. M. Chinnaiyan, F. C. Kischel, K. O'Rourke, A. Shevchenko, J. Ni, C. Scaffidi, J. D. Bretz, M. Zhang, R. Gentz, et al. 1996. FLICE, a novel FADD-homologous ICE/CED-3-like protease, is recruited to the CD95 (Fas/APO-1) death-inducing complex. Cell 85:817.
52. Shi, L., S. Mai, S. Israels, K. Browne, J. A. Trapani, and A. H. Greenberg. 1997. Granzyme B (GraB) autonomously crosses the cell membrane and perforin initiates apoptosis and GrzB nuclear localization. J. Exp. Med. 185:855.
53. Darmon, A. J., D. W. Nicolson, and R. C. Bleackley. 1995. Activation of the apoptotic protease CPP32 by cytotoxic T-cell-derived granzyme B. Nature 377:446.
54. Talanian, R. V., X. H. Yang, J. Turbov, P. Seth, T. Ghayur, C. A. Casiano, K. Orth, and C. J. Froefich. 1997. Granule-mediated killing: pathways for granzyme B-initiated apoptosis. J. Exp. Med. 186:1323.
55. Sarin, A., M. S. Williams, M. A. Alexander-Miller, J. A. Berzofsky, C. M. Zacharchuk, and P. A. Henkart. 1997. Target cell lysis by CTL granule exocytosis is independent of ICE/CED-3 family proteases. Immunity 6:209.
56. Wiley, S. R., K. Schooley, P. J. Smolak, W. S. Din, C. Huang, J. K. Nicholl, G. R. Sutherland, C. A. Smith, and R. G. Goodwin. 1995. Identification and characterization of a new member of the TNF family that induces apoptosis. Immunity 3:673.
57. Wong, B. R., J. Rho, J. Arron, E. Robinson, J. Orlinck, M. Chao, S. Kalachkov, E. Cayani, F. S. Bartlett III, W. N. Frankel, et al. 1997. TRANCE is a novel ligand of the tumor necrosis factor receptor family that activates c-Jun N-terminal kinase in T cells. J. Biol. Chem. 272:25190.
58. Liu, C.-C. B. Perussia, Z. A. Cohn, and J. D.-E. Young. 1986. Identification and characterization of a pore-forming protein of human peripheral blood natural killer cells. J. Exp. Med. 164:2061.
59. Gershenfeld, H. K., R. J. Herschberger, T. B. Shows, and I. L. Weissman. 1988. Cloning and chromosomal assignment of a human cDNA encoding a T cell- and natural killer cell-specific trypsin-like serine protease. Proc. Natl. Acad. Sci. USA 85:1184.
60. Trapani, J. A., J. L. Klein, P. C. White, and B. Dupont. 1988. Molecular cloning of an inducible serine esterase gene from human cytotoxic lymphocytes. Proc. Natl. Acad. Sci. USA 85:6924.
61. Salcedo, T. W., L. Azzoni, S. F. Wolf, and B. Perussia. 1993. Modulation of perforin and granzyme messenger RNA expression in human natural killer cells. J. Immunol. 151:2511.
62. Arase, H., N. Arase, and T. Saito. 1995. Fas-mediated cytotoxicity by freshly isolated natural killer cells. J. Exp. Med. 181:1235.
63. Liu, C., S. Rafii, A. Graniello-Piperno, J. A. Trapani, and J. D-E. Young. 1989. Perforin and serine esterase gene expression in stimulated human T cells: kinetics, mitogen requirements, and effects of cyclosporin A. J. Exp. Med. 170:2105.
64. Suda, T., T. Okazaki, Y. Naito, T. Yokota, N. Arai, K. Ozaki, and S. Nagata. 1995. Expression of Fas ligand in cells of T cell lineage. J. Immunol. 154:3806.
65. + T cell-mediated cytotoxicity. J. Immunol. 152:1127.
66. + cytotoxic T cells. Proc. Natl. Acad. Sci. USA 91:4185.
67. Nastala, C. L., H. D. Edington, T. G. McKinney, H. Tahara, M. A. Nalesnik, M. J. Brunda, M. K. Gately, S. F. Wolf, R. D. Schreiber, W. J. Storkus, et al. 1994. Recombinant IL-12 administration induces tumor regression in association with IFN-γ production. J. Immunol. 153:1697.
68. Luster, A. D., S. M. Greenberg, and P. Leder. 1995. The IP-10 chemokine binds to a specific cell surface heparan sulfate site shared with platelet factor 4 and inhibits endothelial cell proliferation. J. Exp. Med. 182:219.
69. Angiolillo, A. L., C. Sgadari, D. D. Taub, F. Liao, J. M. Farber, S. Maheshwari, H. K. Kleinman, G. H. Reaman, and G. Tosato. 1995. Human interferon-inducible protein 10 is a potent inhibitor of angiogenesis. J. Exp. Med. 182:155.
70. Ghosh, P., K. L. Komschlies, M. Cippitelli, D. L. Longo, J. Subleski, J. Ye, A. Sica, H. A. Young, R. H. Wiltrout, A. C. Ochoa. 1995. Gradual loss of T-helper 1 populations in spleen of mice during progressive tumor growth. J. Natl. Cancer Inst. 87:1478.
71. Mulders, P., R. Figlin, J. B. DeKernion, R. H. Wiltrout, M. Linehan, D. Parkinson, W. deWolf, and A. Belldegrun. 1997. Renal cell carcinoma: recent progress and future directions. Cancer Res. 57:5189.